Predictors for Replanning in Loco-Regionally Advanced Nasopharyngeal Carcinoma Patients Undergoing I

来源 :第七届全国鼻咽癌学术大会 | 被引量 : 0次 | 上传用户:InsideCSharp
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  Background: Replanning in intensity-modulated radiotherapy(IMRT) has been reported to improve quality of life and local regional control in patients with nasopharyngeal cancer(NPC).Determination of the criteria for replanning is, however, urgently needed.We conducted a prospective study to determine when and for what type of patients is replanning preferred through weekly repeat computed tomography (CT) imaging during the course of IMRT.
其他文献
[背景]腺病毒介导的p53肿瘤基因治疗是一种有前景的抗肿瘤手段,通过恢复野生型p53功能,达到抑制肿瘤的目的。在过去的十多年里,大量临床研究表明瘤体内注射、腹膜内注射、膀胱内注射重组人p53腺病毒注射液均是安全有效的抗肿瘤手段。[目的]本研究针对rAd-p53静脉递药系统给药,对重组人p53腺病毒注射液(rAd-p53)联合放化疗治疗晚期鼻咽癌的安全性和近期疗效进行了回顾性研究。
会议
[目的]明确纳米炭—顺铂混悬液对鼻咽癌转移淋巴结有明显治疗效果,证明纳米炭—顺铂混悬液具有靶向化疗作用。[方法]将纳米炭吸附化疗药物顺铂后,注射于鼻咽癌患者鼻咽部病灶,通过纳米炭的靶向输送能力,使化疗药物输送并聚集于鼻咽癌转移的前哨淋巴结,达到定向化疗的目的。严格按照技术要求制备药物后,分两种检验方法进行试验。第一阶段进行纳米炭靶向运药能力研究,设立纳米炭—顺铂混悬液(DDP-CNP)组、顺铂(D
Despite the efficacy of gemcitabine-cisplatin (GC) regimens,the outcome of patients with metastatic nasopharyngeal carcinoma (MNPC) is poor.We conducted a phase Ⅱ trial to determine the safety and eff
Objective:To evaluate the efficacy and safety of a neoadjuvant gemcitabine and nedaplatin chemotherapy regimen followed by concurrent chemoradiotherapy or radiotherapy alone in locoregionally advanced
The aim of this study was to ensure a high dose of intensity modulated radiation therapy(IMRT) was delivered to tumor tissue with a low dose to normal organs.Seldinger interventional techniques were u
会议
Backgroud: For the locogegionally advanced nasopharyngeal carcinoma (NPC) patients, radiotherapy plus chemotherapy has been the gold standard treatment reiment.However, the cisplatin based chemotherap
会议
Background:A randomized phase 3 trial of the treatment of nasopharyngeal carcinoma compared induction chemotherapy with docetaxel plus cisplatin and fluorouracil (TPF) with cisplatin and fluorouracil
Backgroud:Concurrent chemoradiotherapy(CCRT) has been the back-born of locoreginally advanced nasopharyngeal carcinoma (NPC) patients.We report data from our study to assess the efficacy and adverse e
会议
Objective:To investigate the therapeutic efficacy of computed tomography (CT)-guided permanent percutaneous implantation of iodine-125(125I) for treating recurrent nasopharyngeal cancer.
[背景]颅底骨质破坏被认为是鼻咽癌患者一个预后差的指标,并被归于第七版MCC的T3分类,该分期系统是基于二维常规放射治疗作为主要放疗手段及CT作为主要诊断工具的回顾性研究。然而随着放疗技术的发展特别是调强放疗的普遍应用以及影像技术的发展特别是MRI的应用,颅底骨质破坏在鼻咽癌中的预后价值需要重新评估。[目的]探讨基于MRI的颅底骨质破坏在鼻咽癌调强放疗模式下的预后价值;建立一个基于MRI的颅底骨质